BridgeBio Pharma (2CL.F) Q2 2025 Earnings

29AprConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-1.33
-1.01
-0.69
-0.36

Details

Expected EPS
-0.80582983128
Actual EPS
-0.7725168
Surprise EPS
0.03
Surprise Percent
+4.13%

Description

BridgeBio Pharma (2CL.F) has reported earnings of -0.7725168 per share for Q2 2025.

0 Comments

Share your thoughts